| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Atrial Appendage | 16 | 2019 | 120 | 7.20 | Why? |
| Catheter Ablation | 27 | 2020 | 438 | 6.65 | Why? |
| Atrial Fibrillation | 33 | 2019 | 2320 | 5.87 | Why? |
| Tachycardia, Ventricular | 13 | 2019 | 251 | 3.85 | Why? |
| Defibrillators, Implantable | 10 | 2019 | 624 | 2.98 | Why? |
| Atrial Remodeling | 4 | 2018 | 31 | 2.29 | Why? |
| Pacemaker, Artificial | 9 | 2019 | 431 | 2.23 | Why? |
| Arrhythmias, Cardiac | 14 | 2021 | 2510 | 2.13 | Why? |
| Pulmonary Veins | 9 | 2019 | 146 | 2.12 | Why? |
| Electrophysiologic Techniques, Cardiac | 7 | 2021 | 396 | 1.66 | Why? |
| Anti-Arrhythmia Agents | 6 | 2020 | 325 | 1.61 | Why? |
| Phenethylamines | 2 | 2019 | 8 | 1.48 | Why? |
| Cardiac Catheterization | 6 | 2019 | 882 | 1.48 | Why? |
| Septal Occluder Device | 3 | 2018 | 46 | 1.46 | Why? |
| Sympathectomy | 2 | 2019 | 67 | 1.38 | Why? |
| Renal Artery | 2 | 2019 | 66 | 1.36 | Why? |
| Suture Techniques | 2 | 2019 | 138 | 1.31 | Why? |
| Device Removal | 3 | 2018 | 221 | 1.28 | Why? |
| Esophagus | 2 | 2018 | 139 | 1.27 | Why? |
| Heart Atria | 6 | 2018 | 267 | 1.18 | Why? |
| Atrial Function, Left | 5 | 2018 | 82 | 1.08 | Why? |
| Electrocardiography | 10 | 2020 | 3957 | 1.01 | Why? |
| Cardiac Electrophysiology | 3 | 2020 | 239 | 0.98 | Why? |
| Amiodarone | 3 | 2019 | 110 | 0.98 | Why? |
| Surgery, Computer-Assisted | 3 | 2018 | 183 | 0.87 | Why? |
| Tachycardia, Supraventricular | 2 | 2018 | 52 | 0.85 | Why? |
| Monitoring, Intraoperative | 2 | 2018 | 140 | 0.80 | Why? |
| Femoral Vein | 1 | 2019 | 43 | 0.77 | Why? |
| Therapeutic Occlusion | 1 | 2018 | 2 | 0.76 | Why? |
| Vena Cava, Superior | 1 | 2018 | 30 | 0.76 | Why? |
| Hypoglossal Nerve | 1 | 2018 | 5 | 0.75 | Why? |
| Sulfonamides | 2 | 2019 | 1294 | 0.75 | Why? |
| Esophageal Diseases | 1 | 2018 | 34 | 0.73 | Why? |
| Atrioventricular Node | 1 | 2018 | 31 | 0.73 | Why? |
| Alloys | 1 | 2018 | 53 | 0.72 | Why? |
| Magnetics | 2 | 2017 | 66 | 0.72 | Why? |
| Cardiac Surgical Procedures | 5 | 2019 | 1931 | 0.72 | Why? |
| Stenosis, Pulmonary Vein | 1 | 2017 | 5 | 0.71 | Why? |
| Octreotide | 1 | 2017 | 56 | 0.69 | Why? |
| Stroke | 9 | 2019 | 8839 | 0.69 | Why? |
| Arteriovenous Malformations | 1 | 2017 | 33 | 0.68 | Why? |
| Computer Security | 2 | 2018 | 408 | 0.66 | Why? |
| Aldosterone | 1 | 2018 | 155 | 0.65 | Why? |
| Thromboembolism | 4 | 2018 | 2101 | 0.64 | Why? |
| Hypertension | 4 | 2019 | 8895 | 0.64 | Why? |
| Warfarin | 2 | 2018 | 402 | 0.62 | Why? |
| Electric Stimulation Therapy | 1 | 2018 | 151 | 0.62 | Why? |
| Heart-Assist Devices | 3 | 2019 | 812 | 0.61 | Why? |
| Hemorrhage | 2 | 2019 | 3013 | 0.60 | Why? |
| Epinephrine | 1 | 2018 | 323 | 0.59 | Why? |
| Postoperative Complications | 6 | 2019 | 5861 | 0.55 | Why? |
| Cardiomyopathies | 3 | 2018 | 997 | 0.53 | Why? |
| American Heart Association | 3 | 2020 | 347 | 0.53 | Why? |
| Drug Substitution | 1 | 2017 | 385 | 0.52 | Why? |
| Prosthesis-Related Infections | 1 | 2017 | 302 | 0.50 | Why? |
| Treatment Outcome | 29 | 2020 | 51732 | 0.49 | Why? |
| Imaging, Three-Dimensional | 1 | 2017 | 680 | 0.47 | Why? |
| Follow-Up Studies | 16 | 2018 | 17020 | 0.47 | Why? |
| Practice Guidelines as Topic | 5 | 2020 | 15421 | 0.46 | Why? |
| Cardiologists | 1 | 2017 | 366 | 0.46 | Why? |
| Death, Sudden, Cardiac | 1 | 2017 | 522 | 0.45 | Why? |
| Ventricular Dysfunction, Left | 2 | 2017 | 993 | 0.45 | Why? |
| Recurrence | 12 | 2019 | 3675 | 0.45 | Why? |
| Gastrointestinal Hemorrhage | 1 | 2017 | 669 | 0.44 | Why? |
| Primary Prevention | 1 | 2018 | 778 | 0.43 | Why? |
| Stroke Volume | 3 | 2017 | 2153 | 0.42 | Why? |
| Natriuretic Peptide, Brain | 1 | 2018 | 1215 | 0.42 | Why? |
| Hemodynamics | 2 | 2017 | 1562 | 0.41 | Why? |
| Sleep Apnea, Obstructive | 1 | 2018 | 668 | 0.40 | Why? |
| Phlebography | 1 | 2009 | 65 | 0.39 | Why? |
| Registries | 3 | 2018 | 12327 | 0.38 | Why? |
| Heart Defects, Congenital | 1 | 2018 | 933 | 0.38 | Why? |
| Continuous Positive Airway Pressure | 1 | 2018 | 1187 | 0.38 | Why? |
| Cardiology | 3 | 2020 | 2873 | 0.37 | Why? |
| Tricuspid Valve | 2 | 2019 | 91 | 0.36 | Why? |
| Health Care Costs | 1 | 2017 | 1007 | 0.36 | Why? |
| Heart | 1 | 2018 | 1791 | 0.36 | Why? |
| Ligation | 2 | 2018 | 84 | 0.35 | Why? |
| Heart Rate | 5 | 2019 | 1527 | 0.33 | Why? |
| Prostheses and Implants | 2 | 2018 | 116 | 0.32 | Why? |
| Aged | 38 | 2019 | 215776 | 0.32 | Why? |
| Echocardiography, Transesophageal | 3 | 2019 | 447 | 0.31 | Why? |
| Humans | 75 | 2021 | 930598 | 0.29 | Why? |
| Kidney | 1 | 2019 | 3648 | 0.27 | Why? |
| Female | 45 | 2020 | 380317 | 0.27 | Why? |
| Male | 44 | 2020 | 367725 | 0.27 | Why? |
| Retrospective Studies | 23 | 2019 | 105322 | 0.25 | Why? |
| Infection Control | 3 | 2020 | 23131 | 0.24 | Why? |
| Equipment Design | 6 | 2018 | 3095 | 0.24 | Why? |
| Pericardial Effusion | 2 | 2017 | 312 | 0.24 | Why? |
| Anticoagulants | 4 | 2018 | 9563 | 0.23 | Why? |
| Elective Surgical Procedures | 1 | 2020 | 5338 | 0.23 | Why? |
| Action Potentials | 3 | 2017 | 368 | 0.23 | Why? |
| Stents | 1 | 2009 | 916 | 0.22 | Why? |
| Middle Aged | 29 | 2019 | 270681 | 0.22 | Why? |
| Time Factors | 10 | 2019 | 31397 | 0.21 | Why? |
| United States | 13 | 2020 | 46150 | 0.21 | Why? |
| Body Surface Potential Mapping | 2 | 2017 | 20 | 0.21 | Why? |
| Heart Conduction System | 1 | 2003 | 266 | 0.21 | Why? |
| Feasibility Studies | 3 | 2019 | 3467 | 0.20 | Why? |
| Randomized Controlled Trials as Topic | 6 | 2019 | 10649 | 0.20 | Why? |
| Punctures | 1 | 2019 | 89 | 0.19 | Why? |
| Electromagnetic Fields | 1 | 2019 | 34 | 0.19 | Why? |
| Electrocardiography, Ambulatory | 1 | 2021 | 204 | 0.19 | Why? |
| Hemostatic Techniques | 1 | 2019 | 60 | 0.19 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.19 | Why? |
| Prosthesis Implantation | 2 | 2019 | 261 | 0.19 | Why? |
| Venous Thrombosis | 2 | 2017 | 2739 | 0.19 | Why? |
| Telemedicine | 8 | 2021 | 25032 | 0.18 | Why? |
| Deep Sedation | 1 | 2019 | 121 | 0.18 | Why? |
| Sutures | 1 | 2018 | 57 | 0.18 | Why? |
| Electric Countershock | 2 | 2017 | 284 | 0.18 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.18 | Why? |
| Stereotaxic Techniques | 1 | 2017 | 19 | 0.18 | Why? |
| Cardiac Catheters | 1 | 2018 | 44 | 0.18 | Why? |
| Equipment Safety | 1 | 2019 | 167 | 0.17 | Why? |
| Denervation | 1 | 2017 | 26 | 0.17 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.17 | Why? |
| Telemetry | 1 | 2020 | 240 | 0.17 | Why? |
| Systole | 1 | 2018 | 252 | 0.17 | Why? |
| Kansas | 1 | 2017 | 44 | 0.17 | Why? |
| Atrial Flutter | 1 | 2019 | 143 | 0.17 | Why? |
| Conscious Sedation | 1 | 2019 | 222 | 0.17 | Why? |
| Blood Pressure | 2 | 2019 | 2198 | 0.17 | Why? |
| Electroshock | 1 | 2016 | 7 | 0.17 | Why? |
| Risk Factors | 12 | 2019 | 71621 | 0.17 | Why? |
| Cardiac Imaging Techniques | 1 | 2020 | 357 | 0.17 | Why? |
| Catheters | 1 | 2017 | 93 | 0.17 | Why? |
| Pressure | 1 | 2019 | 289 | 0.17 | Why? |
| Tomography, X-Ray Computed | 2 | 2017 | 25144 | 0.16 | Why? |
| Patient Selection | 3 | 2020 | 4560 | 0.16 | Why? |
| Survival Rate | 5 | 2020 | 9206 | 0.16 | Why? |
| Risk Assessment | 7 | 2020 | 25439 | 0.16 | Why? |
| Polysomnography | 1 | 2018 | 296 | 0.16 | Why? |
| Cicatrix | 1 | 2017 | 129 | 0.16 | Why? |
| Sodium | 1 | 2018 | 309 | 0.16 | Why? |
| Pandemics | 10 | 2020 | 389249 | 0.16 | Why? |
| Nasal Sprays | 1 | 2018 | 234 | 0.16 | Why? |
| Balloon Occlusion | 1 | 2016 | 39 | 0.16 | Why? |
| Magnesium | 1 | 2018 | 290 | 0.15 | Why? |
| Potassium | 1 | 2018 | 325 | 0.15 | Why? |
| Subacute Care | 1 | 2020 | 315 | 0.15 | Why? |
| Equipment Failure | 1 | 2017 | 197 | 0.15 | Why? |
| Operative Time | 1 | 2017 | 450 | 0.15 | Why? |
| Societies, Medical | 3 | 2021 | 6907 | 0.15 | Why? |
| Injections, Subcutaneous | 1 | 2017 | 647 | 0.15 | Why? |
| Ventricular Fibrillation | 1 | 2016 | 126 | 0.15 | Why? |
| Quality-Adjusted Life Years | 1 | 2018 | 511 | 0.14 | Why? |
| Models, Economic | 1 | 2018 | 316 | 0.14 | Why? |
| Calcium Channel Blockers | 1 | 2018 | 367 | 0.14 | Why? |
| Organizational Policy | 1 | 2020 | 694 | 0.14 | Why? |
| Endoscopy, Digestive System | 1 | 2018 | 352 | 0.14 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.14 | Why? |
| Colectomy | 1 | 2017 | 327 | 0.13 | Why? |
| Cardiology Service, Hospital | 1 | 2021 | 602 | 0.13 | Why? |
| Databases, Factual | 3 | 2017 | 6248 | 0.13 | Why? |
| Homeostasis | 1 | 2018 | 582 | 0.13 | Why? |
| Risk Adjustment | 1 | 2018 | 730 | 0.13 | Why? |
| Return to Work | 1 | 2020 | 579 | 0.13 | Why? |
| Delivery of Health Care | 1 | 2020 | 15909 | 0.13 | Why? |
| Prospective Studies | 5 | 2018 | 43301 | 0.13 | Why? |
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 669 | 0.13 | Why? |
| Aged, 80 and over | 12 | 2019 | 88759 | 0.13 | Why? |
| Emergency Treatment | 1 | 2019 | 719 | 0.13 | Why? |
| Heart Failure | 4 | 2018 | 6638 | 0.13 | Why? |
| Gastrointestinal Agents | 1 | 2017 | 393 | 0.12 | Why? |
| Causality | 1 | 2017 | 857 | 0.12 | Why? |
| Body Temperature | 1 | 2018 | 875 | 0.12 | Why? |
| Patient Safety | 2 | 2017 | 4885 | 0.12 | Why? |
| Creatinine | 1 | 2018 | 1443 | 0.12 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.11 | Why? |
| Treatment Failure | 1 | 2017 | 2106 | 0.11 | Why? |
| Factor Xa Inhibitors | 1 | 2016 | 490 | 0.11 | Why? |
| Triage | 2 | 2020 | 7151 | 0.11 | Why? |
| Incidence | 5 | 2020 | 25622 | 0.10 | Why? |
| Monitoring, Physiologic | 2 | 2020 | 1956 | 0.10 | Why? |
| United States Food and Drug Administration | 1 | 2017 | 1276 | 0.10 | Why? |
| Medicare | 1 | 2017 | 1048 | 0.10 | Why? |
| Prognosis | 6 | 2020 | 32490 | 0.10 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.10 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.10 | Why? |
| Coronary Angiography | 1 | 2019 | 2275 | 0.10 | Why? |
| Radiographic Image Enhancement | 1 | 2009 | 89 | 0.09 | Why? |
| Predictive Value of Tests | 3 | 2020 | 9537 | 0.09 | Why? |
| Ventricular Function, Left | 1 | 2017 | 1555 | 0.09 | Why? |
| Aging | 1 | 2003 | 3581 | 0.08 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.08 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2020 | 1876 | 0.08 | Why? |
| Forecasting | 2 | 2021 | 4492 | 0.08 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.08 | Why? |
| Reoperation | 2 | 2019 | 544 | 0.07 | Why? |
| Remote Consultation | 1 | 2020 | 2396 | 0.07 | Why? |
| Comorbidity | 3 | 2020 | 34796 | 0.07 | Why? |
| Kaplan-Meier Estimate | 3 | 2018 | 4260 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Cohort Studies | 2 | 2018 | 36005 | 0.07 | Why? |
| Echocardiography | 1 | 2018 | 3661 | 0.07 | Why? |
| Europe | 2 | 2017 | 12702 | 0.06 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Heart Diseases | 1 | 2019 | 3503 | 0.06 | Why? |
| Adult | 9 | 2019 | 244371 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.06 | Why? |
| Amyloidosis | 1 | 2003 | 178 | 0.06 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| Automobiles | 1 | 2019 | 88 | 0.05 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.05 | Why? |
| Bioprosthesis | 1 | 2019 | 126 | 0.04 | Why? |
| Fluoroscopy | 1 | 2018 | 140 | 0.04 | Why? |
| Torsades de Pointes | 1 | 2020 | 229 | 0.04 | Why? |
| Dose-Response Relationship, Drug | 2 | 2018 | 3776 | 0.04 | Why? |
| Coronary Disease | 1 | 2003 | 645 | 0.04 | Why? |
| Weapons | 1 | 2016 | 4 | 0.04 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.04 | Why? |
| Echocardiography, Doppler, Color | 1 | 2017 | 114 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.04 | Why? |
| International Cooperation | 2 | 2021 | 3436 | 0.04 | Why? |
| Premedication | 1 | 2016 | 40 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Severity of Illness Index | 3 | 2020 | 48226 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Heart Valve Diseases | 1 | 2019 | 355 | 0.04 | Why? |
| Proportional Hazards Models | 2 | 2018 | 6543 | 0.04 | Why? |
| Law Enforcement | 1 | 2016 | 113 | 0.04 | Why? |
| Risk | 2 | 2018 | 5288 | 0.04 | Why? |
| Pericardium | 1 | 2017 | 228 | 0.04 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Fibrosis | 1 | 2017 | 800 | 0.03 | Why? |
| Models, Animal | 1 | 2016 | 788 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2017 | 1654 | 0.03 | Why? |
| Young Adult | 3 | 2018 | 93724 | 0.03 | Why? |
| Program Evaluation | 1 | 2020 | 1929 | 0.03 | Why? |
| Organizational Innovation | 1 | 2021 | 2468 | 0.03 | Why? |
| Long QT Syndrome | 1 | 2020 | 1047 | 0.03 | Why? |
| Activities of Daily Living | 1 | 2019 | 1530 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.03 | Why? |
| Adolescent | 2 | 2017 | 86841 | 0.02 | Why? |
| Drug Administration Schedule | 1 | 2016 | 2324 | 0.02 | Why? |
| Long-Term Care | 1 | 2020 | 2047 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.02 | Why? |
| Sensitivity and Specificity | 1 | 2009 | 22971 | 0.02 | Why? |
| Workplace | 1 | 2020 | 2075 | 0.02 | Why? |
| Hospitalization | 1 | 2019 | 54280 | 0.02 | Why? |
| Swine | 1 | 2016 | 3352 | 0.02 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Smoking | 1 | 2018 | 3358 | 0.02 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.02 | Why? |
| Mortality | 1 | 2020 | 7132 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Patient Discharge | 1 | 2017 | 5696 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.01 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.01 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.01 | Why? |
| Animals | 1 | 2016 | 78931 | 0.00 | Why? |